RxPepsDirect review

RxPepsDirect publishes a per-vial catalog of roughly seventy items with the molecule, the strength and the total milligrams against each price. Sermorelin at $80 for 15 mg and NAD⁺ injectable at $100 for 1,000 mg are comparable units in a way that "sermorelin from $199/mo" never is. It names its 503A pharmacy, its medical director and its lead prescriber, and it publishes independent sterility and endotoxin testing. What you are buying alongside that specificity is a thin clinical layer: a two-minute asynchronous form, no live video, no labs, and a $39 visit fee that recurs on every refill.

RxPepsDirect (Peptide RX LLC) is a telehealth platform selling compounded peptides and GLP-1 medications from a single per-vial catalog, organized into eight categories. Growth-hormone secretagogues cover sermorelin at $80 for 15 mg, sermorelin/ipamorelin at $100, CJC-1295/ipamorelin at $100 for 10 mg + 10 mg, tesamorelin at $100 for 15 mg and a high-dose tesamorelin at $200. Recovery covers BPC-157 at $80 for 15 mg, BPC-157/TB-500/KPV blends, ARA-290, GHK-Cu at $80 for 50 mg and thymosin alpha-1. Longevity covers NAD⁺ injectable at $100 for 1,000 mg, an NAD⁺ nasal spray at $150 for 15 mL, epithalon, MOTS-C and glutathione at $20 for 2,000 mg. Sexual health covers PT-141 at $75 for 10 mg and gonadorelin at $35 for 1 mg. Compounded semaglutide and tirzepatide sit on the weight-loss shelf.

Asynchronous and deliberately fast. You complete an adaptive online health intake, a licensed nurse practitioner or physician assistant reviews it without a live visit, and a patient-specific prescription — if issued — is dispensed under Section 503A. The prescribing side is properly identified: a named medical director in Dr. Jonathan Snipes, MD, a named lead prescriber in Kim Callender, FNP-BC, both with public NPI numbers you can check, and a named dispensing pharmacy, Optimal Balance Pharmacy in Texas, holding a state board license for sterile compounding. Batch testing is published rather than asserted, through an FDA-registered, ISO 17025-accredited lab. That is a traceable chain end to end. The clinical rigor behind it is another matter, and we would rather say so plainly than let the disclosure quality carry it: one $39 asynchronous review covers up to three peptides at once, no labs are required for any of them, no dose-escalation monitoring protocol is published, and there is no live video option. For an injectable prescription, three molecules cleared by one form is a lot of latitude. The company was founded in 2026 and holds no LegitScript certification, and it serves 28 states plus DC — not California, and not most of the Southeast.

Per vial, and unusually legible for it. Every item states the total milligrams beside the price, so you can compute a cost per dose instead of comparing two unlabeled monthly fees: sermorelin $80 for 15 mg, sermorelin/ipamorelin $100, CJC-1295/ipamorelin $100 for 10 mg + 10 mg, tesamorelin $100 for 15 mg, BPC-157 $80 for 15 mg, GHK-Cu $80 for 50 mg, PT-141 $75 for 10 mg, gonadorelin $35 for 1 mg, NAD⁺ injectable $100 for 1,000 mg, NAD⁺ nasal spray $150 for 15 mL, glutathione $20 for 2,000 mg. There is no monthly price to quote because there is no month here — the model is explicitly no subscription, no commitment, pay when you order. Two costs sit outside the vial and are easy to miss: a $39 medical visit fee charged on every prescription including refills, and $15 flat overnight shipping per order. A single vial ordered twice a quarter carries $78 of visit fees a year on top of the medication. The $39 covering up to three peptides is why the catalog is priced the way it is, and it is also the reason the cost model rewards buying several molecules at once.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The chain here is genuinely traceable — a named 503A sterile compounder, a named medical director, published third-party sterility and endotoxin results — and compounded sterile products are still not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, a catalog this wide is far wider than the data behind it. Sermorelin, sermorelin/ipamorelin and CJC-1295/ipamorelin act on the growth-hormone axis through a real, well-characterized mechanism whose long-term human outcome data stays thin. Tesamorelin is an approved drug, but for HIV-associated lipodystrophy specifically, so other prescribing is off-label. BPC-157, TB-500, GHK-Cu, thymosin alpha-1, MOTS-C and epithalon have essentially no controlled human outcome trials. Injected and intranasal NAD⁺ have none either; the NAD⁺ forms with human trial data are the oral precursors NR and NMN, and what those trials show is a raised blood NAD⁺ level. Glutathione has essentially no controlled human outcome data. PT-141 is approved for one narrow indication in premenopausal women, so other prescribing is off-label. Gonadorelin is a GnRH analog used to preserve testicular function alongside testosterone rather than a standalone therapy. Individual results vary.